N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

N-alpha acetyltransferase N-terminal acetylation N-terminal myristoylation N-terminal proteoforms NAA40 NMT1 Naa40S alternative translation initiation biotin-dependent proximity labeling (BioID)

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
01 Apr 2021
Historique:
received: 26 02 2021
revised: 28 03 2021
accepted: 28 03 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 18 5 2021
Statut: epublish

Résumé

The evolutionary conserved N-alpha acetyltransferase Naa40p is among the most selective N-terminal acetyltransferases (NATs) identified to date. Here we identified a conserved N-terminally truncated Naa40p proteoform named Naa40p25 or short Naa40p (Naa40

Identifiants

pubmed: 33916271
pii: ijms22073690
doi: 10.3390/ijms22073690
pmc: PMC8037211
pii:
doi:

Substances chimiques

Histones 0
Lge1 protein, S cerevisiae 0
Protein Isoforms 0
Saccharomyces cerevisiae Proteins 0
Transcription Factors 0
N-Terminal Acetyltransferase D EC 2.3.1.257
NAA40 protein, human EC 2.3.1.257

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fonds Wetenschappelijk Onderzoek
ID : G.0269.13N

Références

Mol Cell Proteomics. 2018 Apr;17(4):694-708
pubmed: 29317475
Biochemistry. 2012 Nov 6;51(44):8856-66
pubmed: 23102099
Mol Cell Proteomics. 2014 Aug;13(8):2031-41
pubmed: 24408909
Proteomics. 2011 Aug;11(15):3012-22
pubmed: 21674803
BMC Proc. 2009 Aug 04;3 Suppl 6:S6
pubmed: 19660099
Proc Natl Acad Sci U S A. 1982 Oct;79(20):6128-31
pubmed: 6959104
BMC Proc. 2009 Aug 04;3 Suppl 6:S2
pubmed: 19660095
J Proteome Res. 2014 Jun 6;13(6):3107-13
pubmed: 24816145
Sci Signal. 2013 Nov 19;6(302):rs15
pubmed: 24255178
Mol Cell Proteomics. 2016 Nov;15(11):3361-3372
pubmed: 27694331
Nat Protoc. 2011 Jul 14;6(8):1130-41
pubmed: 21799483
Mol Cell Proteomics. 2019 Jan;18(1):115-126
pubmed: 30341083
Trends Biochem Sci. 2016 Sep;41(9):746-760
pubmed: 27498224
Proteomics. 2004 Jun;4(6):1626-32
pubmed: 15174132
J Proteome Res. 2021 Feb 5;20(2):1229-1242
pubmed: 33356293
PLoS Genet. 2011 Jul;7(7):e1002169
pubmed: 21750686
Proc Natl Acad Sci U S A. 2009 May 19;106(20):8157-62
pubmed: 19420222
PLoS One. 2008 Apr 23;3(4):e1994
pubmed: 18431481
Methods Mol Biol. 2013;981:115-26
pubmed: 23381857
Protein Sci. 1999 May;8(5):978-84
pubmed: 10338008
J Lipid Res. 2012 Mar;53(3):358-67
pubmed: 22231784
J Biol Chem. 1998 Mar 20;273(12):6595-8
pubmed: 9506952
Nucleic Acids Res. 2017 Jul 27;45(13):7997-8013
pubmed: 28541577
J Cell Sci. 1993 Jul;105 ( Pt 3):613-28
pubmed: 7691845
Elife. 2020 Feb 28;9:
pubmed: 32109204
Nucleic Acids Res. 2017 Jan 4;45(D1):D1064-D1074
pubmed: 27899614
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Archaea. 2010 Sep 16;2010:
pubmed: 20885971
PLoS Biol. 2009 Nov;7(11):e1000236
pubmed: 19885390
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Methods Mol Biol. 2011;746:21-37
pubmed: 21607850
Oncogene. 2006 Feb 2;25(5):781-94
pubmed: 16186797
PLoS Genet. 2013;9(9):e1003805
pubmed: 24068969
Biochem Biophys Res Commun. 2007 Feb 2;353(1):18-25
pubmed: 17161380
BMC Bioinformatics. 2012;13 Suppl 16:S12
pubmed: 23176165
Structure. 2015 Feb 3;23(2):332-41
pubmed: 25619998
PLoS One. 2011;6(9):e24713
pubmed: 21935442
Apoptosis. 2016 Mar;21(3):298-311
pubmed: 26666750
Nat Methods. 2019 Nov;16(11):1087-1093
pubmed: 31659326
FEBS J. 2011 Oct;278(20):3822-34
pubmed: 21736701
Nucleic Acids Res. 2020 Jan 8;48(D1):D1153-D1163
pubmed: 31665479
Mol Cell Proteomics. 2012 Jun;11(6):M111.015131
pubmed: 22223895
Nat Commun. 2014 Sep 26;5:4919
pubmed: 25255805
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
BMC Biochem. 2014 Sep 10;15:21
pubmed: 25208769
Nature. 2020 Apr;580(7803):402-408
pubmed: 32296183
Nucleic Acids Res. 2010 Nov;38(21):7388-99
pubmed: 20663773
J Proteome Res. 2007 Jun;6(6):2195-204
pubmed: 17444671
Mol Cell Proteomics. 2014 May;13(5):1245-61
pubmed: 24623590
Arch Biochem Biophys. 2005 Jan 1;433(1):212-26
pubmed: 15581578
Biotechniques. 2014 Sep 01;57(3):115-24
pubmed: 25209046
Trends Biochem Sci. 2020 Jul;45(7):619-632
pubmed: 32305250
Mol Cell Proteomics. 2002 May;1(5):376-86
pubmed: 12118079
Mol Cell Biol. 2009 Jun;29(11):2913-24
pubmed: 19332560
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
FEMS Microbiol Rev. 2020 Jul 1;44(4):418-431
pubmed: 32386204
Int J Biochem Cell Biol. 2009 Dec;41(12):2528-37
pubmed: 19695338
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Gene. 2018 Feb 20;644:27-37
pubmed: 29247799
J Biol Chem. 2003 Oct 3;278(40):38109-12
pubmed: 12915400
Mol Syst Biol. 2016 Feb 18;12(2):858
pubmed: 26893308
Curr Opin Chem Biol. 2009 Oct;13(4):382-91
pubmed: 19699139
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4399-4404
pubmed: 29581253

Auteurs

Veronique Jonckheere (V)

Department of Biochemistry and Microbiology, Ghent University, K. L. Ledeganckstraat 35, 9000 Ghent, Belgium.

Petra Van Damme (P)

Department of Biochemistry and Microbiology, Ghent University, K. L. Ledeganckstraat 35, 9000 Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH